This is the authors' abstract. We don't add key points for this paper.
To describe a "wearing off" phenomenon between standard maintenance infusions of ravulizumab for a subset of patients with acetylcholine receptor antibody positive generalized myasthenia (AChR gMG).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: